Transcription Factor HES-1: How Is the Expression of This Transcriptional Factor in Paucibacillary Leprosy Patients?

Héctor Serrano-Coll1,2, Juan Pablo Ospina-Gómez3, Carolina Salamanca2

  • 1Instituto Colombiano de Medicina Tropical-Universidad CES, Medellín, Colombia.

Abstract

Insights

HES-1, a Notch pathway component, is reduced in paucibacillary (PB) leprosy skin. This finding suggests HES-1 can serve as a diagnostic biomarker for both PB and multibacillary (MB) leprosy.

Area of Science:

  • Dermatology
  • Infectious Diseases
  • Molecular Biology

Background:

  • Leprosy is a chronic infectious disease caused by Mycobacterium leprae and Mycobacterium lepromatosis.
  • The Notch signaling pathway component, HES-1, has been implicated in leprosy pathogenesis.
  • HES-1 may be a useful target for leprosy detection.

Purpose of the Study:

  • To investigate the expression levels of HES-1 in the skin of patients diagnosed with paucibacillary (PB) leprosy.
  • To evaluate HES-1 as a potential diagnostic biomarker for leprosy.

Main Methods:

  • A descriptive, observational study involving 45 leprosy skin samples (30 MB, 15 PB).
  • Immunohistochemistry was used to assess HES-1 and S-100 expression.
  • Statistical analysis compared findings in PB leprosy patients to a control group.

Main Results:

  • Reduced HES-1 expression was observed in the epidermis (66.7%), eccrine glands (80%), and hair follicles (62.5%) of PB leprosy patients.
  • These reductions were statistically significant compared to controls (P < 0.0001).
  • HES-1 demonstrated comparable utility to S-100 in detecting both MB and PB leprosy.

Conclusions:

  • HES-1, a transcriptional factor, is downregulated in the epidermis and skin appendages of PB leprosy patients.
  • HES-1 shows potential as a valuable biomarker for diagnosing both paucibacillary and multibacillary leprosy.
  • Further research into HES-1's role could enhance leprosy diagnostics.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
297
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
294
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
409
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
225